- Home
- RCKT vs AMC Comparison
RCKT vs AMC Comparison
Compare RCKT & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- AMC
- Stock Information
- Founded
- RCKT 1999
- AMC 1920
- Country
- RCKT United States
- AMC United States
- Employees
- RCKT N/A
- AMC N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- AMC Movies/Entertainment
- Sector
- RCKT Health Care
- AMC Consumer Discretionary
- Exchange
- RCKT Nasdaq
- AMC Nasdaq
- Market Cap
- RCKT 1.3B
- AMC 1.6B
- IPO Year
- RCKT N/A
- AMC 2013
- Fundamental
- Price
- RCKT $12.72
- AMC $4.02
- Analyst Decision
- RCKT Strong Buy
- AMC Sell
- Analyst Count
- RCKT 11
- AMC 5
- Target Price
- RCKT $50.27
- AMC $4.30
- AVG Volume (30 Days)
- RCKT 1.6M
- AMC 17.5M
- Earning Date
- RCKT 02-24-2025
- AMC 02-26-2025
- Dividend Yield
- RCKT N/A
- AMC N/A
- EPS Growth
- RCKT N/A
- AMC N/A
- EPS
- RCKT N/A
- AMC N/A
- Revenue
- RCKT N/A
- AMC $4,435,200,000.00
- Revenue This Year
- RCKT N/A
- AMC N/A
- Revenue Next Year
- RCKT $233,736.97
- AMC $11.07
- P/E Ratio
- RCKT N/A
- AMC N/A
- Revenue Growth
- RCKT N/A
- AMC N/A
- 52 Week Low
- RCKT $11.15
- AMC $2.38
- 52 Week High
- RCKT $31.47
- AMC $11.88
- Technical
- Relative Strength Index (RSI)
- RCKT 47.75
- AMC 39.39
- Support Level
- RCKT $11.56
- AMC $3.98
- Resistance Level
- RCKT $12.32
- AMC $4.15
- Average True Range (ATR)
- RCKT 0.71
- AMC 0.17
- MACD
- RCKT 0.20
- AMC -0.02
- Stochastic Oscillator
- RCKT 66.81
- AMC 25.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, premium presentation. The Company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.